CDON Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

CDON şirketinin toplam hissedar öz sermayesi SEK606.4M ve toplam borcu SEK7.3M olup, bu da borç-öz sermaye oranını 1.2% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla SEK807.2M ve SEK200.8M dir.

Anahtar bilgiler

1.2%

Borç/özkaynak oranı

SEK 7.30m

Borç

Faiz karşılama oranı	n/a
Nakit	SEK 67.60m
Eşitlik	SEK 606.40m
Toplam yükümlülükler	SEK 200.80m
Toplam varlıklar	SEK 807.20m

Son finansal sağlık güncellemeleri

Recent updates

There's Reason For Concern Over CDON AB's (STO:CDON) Massive 28% Price Jump

Oct 28

Risks Still Elevated At These Prices As CDON AB (STO:CDON) Shares Dive 25%

Sep 13

More Unpleasant Surprises Could Be In Store For CDON AB's (STO:CDON) Shares After Tumbling 30%

Apr 26

A Look At The Intrinsic Value Of CDON AB (STO:CDON)

Mar 26

Companies Like CDON (STO:CDON) Can Afford To Invest In Growth

Jan 05

Companies Like CDON (STO:CDON) Are In A Position To Invest In Growth

Sep 16

Benign Growth For CDON AB (STO:CDON) Underpins Stock's 27% Plummet

Jul 14

We're Hopeful That CDON (STO:CDON) Will Use Its Cash Wisely

Oct 25

CDON AB's (STO:CDON) About To Shift From Loss To Profit

Mar 20

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: CDON 'nin kısa vadeli varlıkları ( SEK135.3M ) kısa vadeli yükümlülüklerini ( SEK191.8M ) kapsamıyor.

Uzun Vadeli Yükümlülükler: CDON şirketinin kısa vadeli varlıkları ( SEK135.3M ) uzun vadeli yükümlülüklerini ( SEK9.0M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: CDON şirketinin toplam borcundan daha fazla nakiti var.

Borcun Azaltılması: CDON şirketinin borç/öz sermaye oranı son 5 yılda 0% seviyesinden 1.2% seviyesine yükseldi.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: CDON şirketinin mevcut serbest nakit akışına göre bir yıldan az nakit akışı süresi bulunmaktadır.

Tahmini Nakit Akışı: CDON un, serbest nakit akışı her yıl % 48 oranında tarihi oranda azalmaya devam ederse bir yıldan az nakit akışı süresi vardır

CDON Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Companies Like CDON (STO:CDON) Can Afford To Invest In Growth

Companies Like CDON (STO:CDON) Are In A Position To Invest In Growth

We're Hopeful That CDON (STO:CDON) Will Use Its Cash Wisely

Recent updates

There's Reason For Concern Over CDON AB's (STO:CDON) Massive 28% Price Jump

New major risk - Financial position

Third quarter 2024 earnings released

Cdon AB Appoints Nomination Committee Ahead of Annual General Meeting 2025

New minor risk - Share price stability

Risks Still Elevated At These Prices As CDON AB (STO:CDON) Shares Dive 25%

New minor risk - Market cap size

Second quarter 2024 earnings released: kr3.18 loss per share (vs kr3.49 loss in 2Q 2023)

First quarter 2024 earnings released

More Unpleasant Surprises Could Be In Store For CDON AB's (STO:CDON) Shares After Tumbling 30%

Now 20% undervalued

CDON AB, Annual General Meeting, May 07, 2024

CDON AB to Report Q1, 2024 Results on Apr 25, 2024

A Look At The Intrinsic Value Of CDON AB (STO:CDON)

Full year 2023 earnings released: kr6.38 loss per share (vs kr23.25 loss in FY 2022)

New minor risk - Share price stability

CDON AB to Report Q4, 2023 Results on Feb 15, 2024

Companies Like CDON (STO:CDON) Can Afford To Invest In Growth

CDON AB Announces Resignation of Thomas Pehrsson as Deputy CEO , Effective from March 1, 2024

New minor risk - Share price stability

Third quarter 2023 earnings released

Companies Like CDON (STO:CDON) Are In A Position To Invest In Growth

Second quarter 2023 earnings released

Benign Growth For CDON AB (STO:CDON) Underpins Stock's 27% Plummet

CDON AB Approves Board Appointments

Full year 2022 earnings released: kr23.25 loss per share (vs kr10.18 loss in FY 2021)

Full year 2022 earnings released: kr23.28 loss per share (vs kr10.18 loss in FY 2021)

CDON AB (OM:CDON) agreed to acquire Fyndiq AB for SEK 735 million.

Insider recently sold kr310k worth of stock

CDON AB Announces CEO Changes, Effective from 1 January 2023

No independent directors

Third quarter 2022 earnings released: kr3.80 loss per share (vs kr1.38 loss in 3Q 2021)

CDON AB, Annual General Meeting, May 09, 2023

CDON AB, Annual General Meeting, May 09, 2023

CDON AB to Report Q4, 2022 Results on Feb 16, 2023

Second quarter 2022 earnings released

Cdon AB Approves Election of Jonathan Sundqvist and Jonas Calles as Members of the Board of Directors for the Period Until the End of the Next Annual General Meeting

No independent directors

Full year 2021 earnings: EPS and revenues miss analyst expectations

CDON AB to Report Q3, 2022 Results on Oct 20, 2022

CDON AB to Report Q1, 2022 Results on Apr 21, 2022

Full year 2021 earnings: EPS and revenues miss analyst expectations

CDON AB Appoints Madeilene Södarv as Chief Customer Officer, Effective on April 02, 2022

CDON Recruits Martin Lundhgren for the Role of Head of Technology, Effective February 21, 2022

CDON AB to Report Q4, 2021 Results on Feb 16, 2022

CDON AB Appoints Thomas Pehrsson as Chief Financial Officer, Effective March 7, 2022

CDON AB Appoints Magnus Nanne as Chief People Officer

CDON AB (OM:CDON) acquired 71.7% stake of Commerce 8 Oy from Ostro 17 Oy for approximately €0.18 million.

We're Hopeful That CDON (STO:CDON) Will Use Its Cash Wisely

Third quarter 2021 earnings released: kr1.24 loss per share (vs kr6.00 profit in 3Q 2020)

Forecast to breakeven in 2021

CDON AB (OM:CDON) entered into an agreement to acquire 30% stake in Shopit Online Europe AB for SEK 26.6 million.

First quarter 2021 earnings released: kr2.30 loss per share

CDON AB's (STO:CDON) About To Shift From Loss To Profit

CDON AB Announces Executive Changes

New 90-day high: kr744

Full year 2020 earnings released: kr0.98 loss per share

CDON AB Proposes No Dividend Be Paid for 2020

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin